<SUBMISSION>
<ACCESSION-NUMBER>0001140361-07-005817
<TYPE>424B3
<PUBLIC-DOCUMENT-COUNT>2
<FILING-DATE>20070316
<DATE-OF-FILING-DATE-CHANGE>20070315
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>BIOSANTE PHARMACEUTICALS INC
<CIK>0001023024
<ASSIGNED-SIC>2836
<IRS-NUMBER>582301143
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B3
<ACT>33
<FILE-NUMBER>333-136852
<FILM-NUMBER>07697633
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>111 BARCLAY BLVD STE 280
<CITY>LINCOLNSHIRE
<STATE>IL
<ZIP>60069
<PHONE>8474780500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>111 BARCLAY BLVD STE 280
<CITY>LINCOLNSHIRE
<STATE>IL
<ZIP>60069
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>BEN ABRAHAM TECHNOLOGIES INC
<DATE-CHANGED>19991027
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>prospectussupplement.htm
<DESCRIPTION>424(B)(3) SUPPLEMENT 1
<TEXT>
<html>
  <head>
    <title>
      424(b)(3) supplement 1
</title>
<!-- Licensed to: EDGARfilings, Ltd.-->
<!-- Document Created using EDGARizer HTML 3.0.4.0 -->
<!-- Copyright 2006 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff"><br>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PROSPECTUS
                SUPPLEMENT NO. 1</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>(to
                Prospectus Dated August 30, 2006)</strong></font></div>
            </td>
            <td align="right" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Filed
                Pursuant to Rule 424(b)(3)</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>File
                No. </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>333-136852</strong></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><img src="biosantelogo6.jpg" alt=""></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>5,147,520
      Shares</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>Common
      Stock</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>___________________</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Prospectus Supplement No. 1 supplements the prospectus dated August 30, 2006
      relating to the 5,147,520 shares of common stock of BioSante Pharmaceuticals,
      Inc. that may be offered for sale for the account of several stockholders of
      BioSante, their respective donees or pledgees, as stated under the heading
&#8220;Plan
      of Distribution&#8221; in the original prospectus. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Prospectus Supplement No. 1 is being filed to update the original table of
      selling stockholders in the original prospectus with respect to a change in
      beneficial ownership that has occurred since the date of the original
      prospectus. This Prospectus Supplement No. 1 is not complete without, and may
      not be delivered or utilized except in connection with, the original prospectus.
      This Prospectus Supplement No. 1 is qualified by reference to the original
      prospectus, except to the extent that the information contained in this
      Prospectus Supplement No. 1 supersedes the information contained in the original
      prospectus.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SELLING
      STOCKHOLDERS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      table
      of selling stockholders in the original prospectus lists Mallette Capital Master
      Fund Ltd., Mallette Capital Biotech Fund L.P., Perceptive Life Sciences Master
      Fund, Ltd. and Quogue Capital LLC as beneficially owning shares issuable upon
      exercise of warrants of which could be offered for sale by these stockholders
      pursuant to the original prospectus. In December 2006, Mallette Capital Master
      Fund Ltd., Mallette Capital Biotech Fund L.P. and Perceptive Life Sciences
      Master Fund, Ltd, respectively, transferred warrants to purchase 48,706, 21,294
      and 175,000 shares, respectively, of BioSante common stock to Warrant Strategies
      Fund LLC. In January 2007, Quogue Capital LLC transferred a warrant to purchase
      87,500 shares of BioSante common stock to Smithfield Fiduciary LLC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      table
      of selling stockholders as it relates to the shares of BioSante common stock
      listed as held by, Mallette Capital Master Fund Ltd., Mallette Capital Biotech
      Fund L.P., Perceptive Life Sciences Master Fund, Ltd. and Quogue Capital LLC
      in
      the original prospectus are hereby updated through March 15, 2007 and amended
      to
      reflect the foregoing as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
            </td>
            <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td align="right" colspan="9" valign="bottom" width="33%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shares
                Beneficially</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Owned
                Prior to the Offering</strong></font>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td align="right" colspan="6" valign="bottom" width="22%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Shares
                Beneficially</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Owned
                After Completion</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Completion
                of </strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>the
                Offering</strong></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Selling
                Stockholder</strong></font></div>
            </td>
            <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Shares
                Subject to Warrants</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">
              <div>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">
              <div>&#160;</div>
            </td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Total
                Shares Beneficially Owned</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">
              <div>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">
              <div>&#160;</div>
            </td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Percentage</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">
              <div>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">
              <div>&#160;</div>
            </td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Number
                of</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Shares</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Being</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Offered</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">
              <div>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">
              <div>&#160;</div>
            </td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Number</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">
              <div>&#160;</div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">
              <div>&#160;</div>
            </td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Percentage</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mallette
                Capital Master Fund Ltd. (1)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">504,818</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2.2</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">139,160</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">365,658</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1.6</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mallette
                Capital Biotech Fund L.P. (1)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">220,582</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1.0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">60,840</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">159,742</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perceptive
                Life Sciences Master Fund,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ltd.
                (2)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">97,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">597,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2.6</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">500,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">97,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Warrant
                Strategies Fund LLC (3)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">245,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">245,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1.1</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">245,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Quogue
                Capital LLC (4)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">11,250</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">250,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1.1</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">%</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">238,750</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">11,250</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Smithfield
                Fiduciary LLC (5)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">87,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">87,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">87,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">__________________________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Less
      than
      one percent (1%)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mallette
      Capital Management, Inc. is the investment advisor of Mallette Capital Master
      Fund Ltd. and Mallette Capital Biotech Fund L.P. and consequently has voting
      control and investment discretion over securities owned by Mallette Capital
      Master Fund Ltd. and Mallette Biotech Fund L.P. Quinterol Mallette, M.D. is
      the
      President of Mallette Capital Management, Inc. As a result, Mallette Capital
      Management, Inc. and Dr. Mallette may be considered the beneficial owner of
      any
      shares deemed to be beneficially owned by Mallette Capital Master Fund Ltd.
      and
      Mallette Biotech Fund L.P.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perceptive
      Advisors, LLC is the investment manager of Perceptive Life Science Master Fund,
      Ltd. and consequently has voting control and investment discretion over
      securities owned by Perceptive Life Science Master Fund, Ltd. Joseph Edelman
      is
      the managing member of Perceptive Advisors, LLC. As a result, Mr. Edelman may
      be
      considered the beneficial owner of any shares deemed to be beneficially owned
      by
      Perceptive Life Science Master Fund, Ltd. Perceptive Life Science Master Fund,
      Ltd. was a 10% or more stockholder of BioSante within the last three
      years.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Hull
      Capital Management, LLC is the sole member of Warrant Strategies Fund LLC.
      Sean
      Molloy, an employee of C.E. Unterberg, Towbin, LLC, the investment manager
      of
      Warrant Strategies Fund LLC, has sole voting and investment control over the
      securities beneficially owned by Warrant Strategies Fund LLC. Mr. Molloy
      disclaims beneficial ownership of such securities. CE Unterberg, Towbin, LLC
      is
      a broker-dealer registered with the National Association of Securities Dealers.
      Although Warrant Strategies Fund LLC is an affiliate of a registered
      broker-dealer, Warrant Strategies Fund LLC has represented to us that it has
      purchased its shares being offered in this offering in the ordinary course
      of
      business and at the time of such purchase, had no agreements or understandings
      to distribute such securities.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Wayne
      Rothbaum, a principal of Quogue Capital LLC, has voting and investment power
      over the securities beneficially owned by Quogue Capital LLC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Highbridge
      Capital Management, LLC is the trading manager of Smithfield Fiduciary LLC
      and
      has voting control and investment discretion over the securities held by
      Smithfield Fiduciary LLC. Glenn Dubin and Henry Swieca control Highbridge
      Capital Management, LLC and have voting control and investment discretion over
      the securities held by Smithfield Fiduciary LLC. Each of Highbridge Capital
      Management, LLC, Glenn Dubin and Henry Swieca disclaims beneficial ownership
      of
      the securities held by Smithfield Fiduciary LLC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>The
      common stock offered involves a high degree of risk. We refer you to &#8220;Risk
      Factors,&#8221; beginning on page 9 of the original prospectus.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
      the Securities and Exchange Commission nor any state securities commission
      has
      approved or disapproved of these securities or determined if this Prospectus
      Supplement No. 1 is truthful or complete. Any representation to the contrary
      is
      a criminal offense. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      date
      of this Prospectus Supplement No. 1 is March 15, 2007</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
  </body>
</html>



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>biosantelogo6.jpg
<DESCRIPTION>BIOSANTE LOGO
<TEXT>
begin 644 biosantelogo6.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`"/`5(#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#S?_A-/%?_
M`$,VL_\`@?+_`/%4'QKXK'_,S:U_X'R__%5A4'I7UWLX=D(]4T_PU\6=4TZU
MO[76]1:WN(EFC<ZP>C?,,C?Z5/\`\(7\8O\`H+ZA_P"#IO\`XNO9O`9SX!\/
M$\G^S;?G_@`J]J'B'1](=4U/5K&R=QN5;FY2,M],FO`EC:BFXJ*T\AGA?_"%
M_&+_`*"^H?\`@[;_`.+I&\&_&5!QJ6J2?36L?^SU[5_PF_A7_H9M&_\``^/_
M`!J>R\3:#J<HAL-;TRYD)QM@NXW;\@33>-K+>*_\!)LCYNUG_A9_AV)I-6OO
M$EO&HYF^W2/&OU=6V_\`CU87_":^*_\`H9M9_P#`^7_XJOL-X8I$9'C5D;[R
MLN0?J*^7/BMX.@\(^*`;)%CL+Y3-#$3PA'WU'H.5Q_O>U=>$QD:SY)Q28[%W
M0M(^*7B72H]2TS7-2FM9&*ASJ[*?E]O,JMXEC^(WA*&";6->U6);ABD6W5'?
MISV<=J]-^$>NZ19?#VU@O-5L;>59I,I+<(C8)X^\U<]\==7TS5--T9+'4;2[
MV3NS"WF63:-O7AJBG7J2Q'LW%6]`L>7_`/":^*_^AFUG_P`#Y?\`XJC_`(33
MQ7_T,VL_^!\O_P`56%17K>SAV0&[_P`)IXK_`.AFUG_P/E_^*H_X33Q7_P!#
M-K/_`('R_P#Q585%'LX=D!N_\)KXK_Z&;6?_``/E_P#BJ/\`A-?%7_0SZS_X
M'R__`!587UK;\'^'I/%7BFPT@$A)7S*0,8C'+?CBE-4X1<FEH!IZ3JOQ"U^;
MRM)U;Q%>/GDPW<K*OU;<%%=7%X/^,;KN;4=5CS_#)K?/Z/7O>EZ39Z+IT6GV
M%O'!;QKM"#O[D]S]:9J.M:9I$8;4-3L[0'^*YG6//YUX<\?)R_=P5O0+'A/_
M``A?QB_Z"^H?^#MO_BZ/^$+^,7_07U#_`,';?_%U[3_PF_A7_H9M&_\``^/_
M`!H_X3;PK_T,VC?^!\7^-+ZY6_D7W"LCQ8>"_C$2!_:^H<_]1MO_`(NN)U#Q
M/XRTW4)[&Z\1:PDT#F.1!J,IY'H=U?3X\;>%,_\`(S:-_P"!T?\`C7RIXKFB
MN_%VK2V[QS1/=,RO&=P(]0177@:LZT^6I%?<.Q)_PFOBO'_(S:S_`.!\O_Q5
M'_":>*_^AFUG_P`#Y?\`XJL*BO3]G#L@-W_A-/%?_0S:S_X'R_\`Q5'_``FG
MBO\`Z&;6?_`^7_XJL*BCV<.R`W?^$T\5_P#0S:S_`.!\O_Q5'_":>*_^AFUG
M_P`#Y?\`XJL*BCV<.R`W?^$T\5_]#-K/_@?+_P#%4?\`":>*_P#H9M9_\#Y?
M_BJPJ*/9P[(#=_X33Q7_`-#-K/\`X'R__%4?\)IXK_Z&;6O_``/E_P#BJPJ*
M/9P[(#=_X37Q5GGQ-K.._P#I\O\`\57<:?X9^+.K:;;:A::UJ+VUU$LT3?VN
MPRK#(_C]Z\JK[!\"`?\`"O\`P]Q_S#H/_0!7!CZOL$N1+7R%$^<?$&I>//"V
MIG3M6\0ZM%=>6'`35'88)SZ^E9)\:>*_^AFUG_P/E_\`BJZWXY<?$1L<?Z+%
M_6O-:ZL.HU*49M*XS=_X33Q7_P!#-K/_`('R_P#Q5'_":>*_^AFUG_P/E_\`
MBJPJ*U]G#L@-W_A-/%?_`$,VL_\`@?+_`/%4?\)IXK_Z&;6?_`^7_P"*K"HH
M]G#L@-W_`(33Q7_T,VL_^!\O_P`50?&OBO'_`",VM?\`@?+_`/%5A4'I0Z<.
MR`^TO#TLDWAK2I97:21[.%G=SDL2@))/<T4WPU_R*NC_`/7E#_Z`**^3G\3&
M?%]!Z44'I7UXC[!\"?\`)/\`P]_V#;?_`-%BO(/VA?\`D/:(>_V:4_\`CU>O
M^`_^1`\/?]@VW_\`0!6?XO\`ASH_C6ZM+G5)KR-[9"L8MI%'!]=RFOF:-6-'
M$.<MD,^3MH]!3E=XG$B,R.ARK*<$'V-?1_\`PH3PC_S]:M_X$)_\15BP^"/@
M^PO5N"M]=[.1!<3`I^(503^=>I/-*#6E_N%8[/PU<W-YX6TFZNRQN9K*&24G
M@LYC4GZ<UY#^T*Z9\/PX!FS,PYZ+\O\`];\C7L>J:K8:!IDEY?SI;6L(^9V[
M>@P*^5O'OBV7QEXEDU'8Z6L:&*UC/41]C]3D_E7!E]-SKJ:V0I'9^!/A#I?B
MWPI!K-SJ%W#/+(X*QHI'!QT-9/Q-^'%CX&M=/FLKNXG-T[QL)5`Q\OM7K7P6
M`_X5M9#`_P!?+_.N:_:%`&F:&<?\O#_^@UO3Q-5XODYM+VL,\%->D^$/@[J_
MB.WCO[^4:;8N`8RZYDE'J%[?C^M0_"+PA#XD\5&YOH=UCIX$KHXR)'/W`1Z<
MYQ[5]*7][:Z78S7MU(L5O"A=V/8"ML;C94Y>RI;]PL>:Q?`/PI''^]N]7E?N
MWG(/TV5EZO\``&Q>-VT;5KF*3^&.\"NK_BHR/RK+U3X^Z@]\W]D:3;BV1L*;
MG<TCCUPO`KN?A]\3K;QI(]C<V_V+4D'F>6&W)*OJI_I7)+Z[3C[63T%H?.WB
M#P[J?A?4FT_5+1H9NJ=U<?WD/<>QKO?@/#')XYN9&P3'9N5R.F2!_(FO8?B%
MX1M_%WA:XM&C'VN)6EMI".5<=OQKP/X6Z]%X=^(%J]X1%#<!K>7<,;">!GZ'
MK76L2\3A9I[H=CZGN7:*UFD099$9E'N!7Q;J=_=:KJUS?WDC27,DC,2_)7D\
M9/85]J'YAZ@CH.017FNL_!3PSJVHS7<<MY9R2L6DCA92ASZ`CBO/P.(IT)/G
MZC/FC`]!1A?05]#_`/#/V@_]!;4?R3_"D?\`9^T(J<:OJ`]\)_A7J_VG0[L#
MYYVC^Z/RI<#@=NPKUWQ#\"=1TZUDN=%OTU':,^3*HBDQ['.TUY'+%)!-)%*C
M+(C89&&"I[@UTT<13K?PV(]6^'OPHT[QEX535;K4+NWF,SQ%8T!'RGWKJ_\`
MAGS1?^@S?_\`?"UYWX/^*VH^#="_LNTTZTN(Q*\F^20CD\UT'_#0.M_]`33\
M^OFM7GU88YS?(]`.B/[/NB@'_B<ZAT_N+6)K'P!O(8'DT75TNG`R(;F(Q[O8
M,,C/Y4V+]H+5DD7S]!M&3IA9F4GZ96O7_"?B:S\8Z%#JEHCHK$JT;CF-AU'O
M7-.KC*'O5'H,^1+RSN=.OI;.\@>&XB8J\;+\P(_I[UU'PZ\(6WC/Q#)IMW<S
M6\2VYF#Q`$G!`[_6N^^/VBQ))I>MQ18EDW03'U`P5SZ]36'\!O\`D>[DXR?L
M3_\`H2UZ$L3*>$]K'1BL=C_PSYHG_0:U#_OE/\*/^&?-$Y_XG6H?]\I_A7I7
MB36#H'AV^U18?/:TB\P1EMN[G&,UX^/VB+C_`*%>+_P./_QNO,I5,953<&W8
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MD3MC=%:P%]O_``-F'/T%=Y\*_"<?AKPA;221XO[Y!<7+G[PR/E3/LN./7)J'
MX@?$ZV\%7$-A%9M>ZA-'YWE%MJQKR,L:FMC*U2K[.B!@#]GW10/FUK4&/KY:
MC^E17?P"T:"SGF76+XM'&S@,BXR!GFL(_M!ZPQ.-"LU`/>5S_P"RTR?X^ZK/
M;2PMHEHJNC*2)6R,C&?NTU3QU]63H>1##X;/!!/3'KC^5!Z&E"E!M(Q@;>N>
MA(/\Z0CBO:7PZC/M#PU_R*NC_P#7E#_Z`**/#7_(JZ/_`->4/_H`HKY&I\;&
M?%]!Z44'I7UPC[!\!_\`(@>'O^P;;_\`H`K!\?\`Q*B\"7]E:R:=)>&ZC:0%
M9`NW:W-;W@/_`)$#P]_V#;?_`-`%>0_M`1/)K^C&.-W7[+*"54G'S=\"OF:%
M.%3$\L]AFG_PT-!_T+\G_@2O^%6;+]H#3+BZ6.]T:Y@A;K)'(),?45X'Y,O_
M`#SD_P"^#5F#2[^_NEMK:TN)IY6VJJ1L2WX$<?C7K3P&%4?^"*Y]F$6>J:>-
MRQW5I<("`RAE=6Z<'BOF;XJ^#+?PAXCC-DNW3[Y#+$A))B9?OKG_`($N/][V
MKZ,\,Z?-I/A?2M/N,":WM(HY,'(W*H#8_&O*?VA7C%GH,;<2F29A_NJ!_4K7
MF8&<HXA16S&=5\%N/AK9?]=I?YUS7[0W_(,T+_KX?_T&NE^"_P#R36R_Z[2_
MSKFOVAO^09H7_7P__H-72_W[YB+7P!M8XO"VI70_UDMT%8_[J\?^A&M/XX7<
MMM\/7AC.U;BYCB<C^[G)_/'ZUSW[/NJ1M9ZQI3,/,619T7N1T8_GBNV^*7A^
M?Q#X#O;:VCWW,)%Q&O\`>*G)7ZD9%35]W&7EW`^4\5T?@"[DLO'FARQMRUVB
M'`QP3S7.N"K%2""#A@1@JWH0:[OX2^'9]:\;V5RL9^RV,OGRR8^7(Y"_GBO;
MQ$HJE)R86/J;`%?&OBJ$6WC#5X4X5;V0?FQ:OL6>=+6WDGE8*D:EF).,`"OB
M_6+O^U=>OKQ?F%S<22Q@@Y(+?*..^*\G*HOGD^@I'=^&/C'XAT"VCM+M(]3M
M8AA1.VR11Z;QU_$5V$?[0ED5'FZ!<@GLLJFO"_*G_P">$G'^R>*/*GSS!)_W
MP:]">!PTW=K\1GO/_#0FF?\`0!O/^_J?XU=TGX[Z%?7B6]WI]Y9+(VT3$JZ`
MD]R#D5\\^3/_`,\)/^^#5_2M`U/6[^.RL;&>69VQCRV^4>I.!C'UK*>`PRC?
M]0N?9B.K`.K`A@"".^>E?,GQIT>/2_'[W$*K''?0K,5QQO'#'^5?2=C`;33[
M6W?YGBA2,GU(`']*^?\`X_3))XKL8$8;X;,[Q[$YKS<O;C7T&RIX`^$T_BNT
M74]0N&LM-=CY2H/WDH'4C/`'O7IUO\$?!L2`/!>3^\D^?Y`5VF@6<-GX>T^W
MB4*B6T:C`P/N@UY'\4_B5XAT+Q7)HVDS):Q0Q(YD\L,[EAGO5^VQ&)J\L)6`
M[`?!?P2IS_9TPQ_T\-_C73^'?#&E^%;!K+287B@9BY#N6Y/UKYK_`.%N>.#Q
M_;;?]^(_\*]H^$7B35/$_ANZO-5NS<3I<&-6*A1C`[`48K#XFG"]65UZ@97Q
M\'_%(6/'_+X/Y&N(^`W_`"/5S_UY/_Z$M=Q\?/\`D4;'_K\_H:X?X"_\CW<_
M]>3_`/H2UM1_W&0CVGXBC_BWFN<#_CV/\Q7R*.*^N_B+_P`D]US_`*]C_,5\
MB5KE/P2%(]F_9ZR=5UW/_/"#_P!">O0?C"!_PK#5>!P8S]/G6O/OV>?^0KKO
M_7"#_P!">O0?C#_R3#5?K'_Z,6N?$_[ZOD,^5R/;M7V%X#_Y)_X=/?\`LZ#G
M_@"U\??X=Z^P/`7/P\\.GC_D&P?^@"M\W^"`HGA'QS`_X6&P_P"G6+^M><Q1
M"66.(\!V"?@37IWQXLY(/',%RZL(I[-2CXX)5BI7Z]_QKR[+)\Z\,OS#Z]JZ
M\(T\.DNPS[>C0)$J*,*!@5R7B'X:^'/$^JMJ.IV]Q)<2($)68J`!TXKH])OX
MM3T>SU"W<&&XA216]05S_6O)?BGX[\5^$/$R0V$D4>G36ZR0EXMP+9P1GU&"
M<>A%>#0A4E5Y:;LQG2#X)>#`,"UNL?\`7P?\*KWWP6\'0Z?<RQVMR'2)V4F<
M]0"1VKRK_A=OC3_G\L__``''^-,F^-/C&:"2*2[M"CJ58"``D$<]Z]%8;&7U
MG^(C@,\9!(#'</8<C]<4'H:4`C*_W3M(Z9.<_I2=C7LI>Z(^T?#7_(JZ/_UY
M0_\`H`HH\-?\BKH__7E#_P"@"BOD:GQLH^+Z#THH/2OKA'V#X#_Y$#P]_P!@
MVW_]`%;LEO#,P,L$;D<`L@.*^:=*U_7HM&LH[?7-0BB6%!'&CC:H].F<5;_X
M23Q%_P!##J/_`']7_P")KY^>!GSMW%SH^BOL=M_S[P_]\#_"G1P10Y,421[N
M3L4#-?.?_"2>(_\`H8=2_P"_J_\`Q--;Q%X@8;3X@U0CU\X#_P!EI?4:C^T'
M.CZ#O]2LM)M'NKZYBMX4&YI)6``_QKY=^)?C,>,_$OGV^X:=:H8[;/5Q_$Y'
M;=CI_LBH]7TZ^U0M)-J=U<R#H+F0L/P!Z5R<L3V\[QNI61>H-=^#P4:4N=N[
M"]SZ=^"P_P"+:V7_`%WE_G7-?M#?\@O0_P#KX?\`]!KS_P`-:UK-EHD<-IK%
M];6X9L1Q.`H_,52\8ZGJ>HPVBW^HW5WL8[?/<':?P`K.GA9+$^TOI>X^;6QF
M^%?$EWX3\0V^KV7.S(DC)QYL9^\I]_3Z5]4>&_%6D^*[!+K3;A7XR\3'YXSZ
M$?UKX\(W_*HSS72:+IM[93+>17EQ9SCH(6*OCT)'6M\9A(5?>O9DWL?2VJ?#
M_P`*ZS=M=WVB6TLY^\Z[E)/J<8%;&FZ3INAV?V;3[2&TMU&2L:X'U)[GZUXA
M;>.O$UM"L2ZM+*>FZ0*Q'Z5C:[K.M^((C'>ZU>[#_P`LU8(OXA:\Y8*K+W92
MT'SHZKXL?$FW-C-X=T6<2R2?+=7,;951_<!]3W/:O*?!*AO&^A(0"OVU/E(R
M.OI67?:?/82!95Q&?NLHXI=+EE@U:VEBD>*5)05=?X3_`(UZU+#QI4>2`7/M
M/[+;_P#/"+_O@4?9;?\`YX1?]\"OG4^)/$>?^1AU+_OZO_Q-)_PDGB/_`*&'
M4O\`OZO_`,37D?4JG\P<R/HO[+;_`//"+_O@4](TC7$:*H]%&*^<3XD\19_Y
M&'4?^_J__$U%/KOB"=&1O$&IX/<2X_D*/J$WU#F1[UX@\3:3X9L9+O4[N.)5
M&0A.78^@'6OE#Q7KTWBKQ%=ZM.K(+@D(I/W8QP!5K5-'N[EVNC>3W<GK/(6;
M'L37.LN/E*G*MSNKT<'@X4M6[L5^8^J?AMXPM/%'A>R02J+^WB$4\.[GY>,C
MVK;UGPCH'B"19-6TFWNI5P`[@AL>Y&*^5=#TZ[#K?1W4]J<X5H7*L?Q%=K'K
M_B!%"C7]3&.,^:#S^5<E7`6J-TY#YTCV/_A5W@D'/_".6O'N_P#C6WHOA_2_
M#UHUMI-BEI`SERD9)!/KS7@G_"2>(_\`H8M2_P"_J_\`Q-)_PD?B(#_D8=1`
M'_35?_B:RE@JLEK,.=';_'S_`)%"Q_Z_/Z&N(^`O_(]W'_7F_P#Z$M<_XNU;
M5;_3HX[[5+V[B$N0L[`J#CM@"LOPE>WUAK$CV5W-:2F(C?`P#8ST.17=3PS6
M%=.^XKZW/IWXB#_BWFN<?\NS?S%?(F.*]%UGQ!KUQHUW%<:Q?RPE,-'(Z_,/
M?`Z5YT1Q5X##NDFF]QWN>R_L\_\`(6UW_KA!_P"A/7H7QA_Y)CJOUC_]#6OG
MWP?J-_87=X=.OYK-I%`)A8`G!/7(K:\2:UK5UH=Q!=ZM>W%NY7,<SC:2/H*Q
MK824L3[2XN=(X`\`\9]O6OI+X.^+K;5/"UOHDTR+?V'[E49L>;&/ND?AQ^%?
M-N#VP#6KHNGW%Q,+N*:2V"$;9(V*L"/0CI77B\/&M3LV.]CZ[UC0-*U^W$&J
MZ?#=1J?E$@Z9]".?2O%/C)X.\/\`AK1--GT?3([.66X8,R;CD;1V)-9,.O:_
M!&J+X@U,(HQGS0?S)%8'B_5M2OK.U%_JEW=QI,2HE;(!QVP!7GX?"U(5$U+8
M.9'<?"3XDVVG6\?AO7)Q%&IQ9W).4'_3,GT'8_AZ5[5<V.FZY9@75M:WMN<E
M=ZB0<\9![?A7QK9:?+?2M'"H8+U)'`'N*[+25U31T"VVM:A",<I%*0H^@.:U
MQ.`BY\\)68<Z1]!'X>>$B<GP_9$GT0C^M5K_`.'WA2/3KITT"S5EA<@A3D$*
M?>O'QXD\18VCQ!J0`[F5?_B:9/XC\0M!*K:_J#*4(*F08(QT/RUS+"5D_C#F
M1YAG*].><=^,"D/0T`G;NY.0<C`'?K0>_%>\E[H7/M#PU_R*NC_]>4/_`*`*
M*/#7_(JZ/_UY0_\`H`HKY&I\;*/B^@T4&OKA';Z=_P`@RS./^6256U35GTZ6
M-!`CJR[LDU9T[_D&6G_7)*Q?$B,]U`R*Q&S^%<URQ492U,8_$+_PDLO_`#Z)
M_P!]4Z/Q/EE$MJ-O^R:PO*D_YY2?]^S3H[:>4JB0R_-_L5MR0*Y4=S&RR1AQ
M\RNNX$=JY_Q+"JSP3J!N?Y3[UNVD3P64$3D%XTV\5@^)95+V\2L-R_,U94_B
MT)C\1HZ%_P`@F,CU:J?BGF*#//S5<T+_`)!,?U:J?BC_`%,'^]50_B%?:*F@
MV23WCS.N4B7TXW5T]S<1VD$DTAPJ#-8_AM,6$K=RW-2>(79=,(`X=U6B>L[`
M]78RI]?O)9&9&1$[#&<5I:3K4EY-]GN0-_4$=#7,8Z\59L79-1MW7J)`#6DJ
M<4KE2BN4Z^_M4O;.6%NNWY3_`':XR"0V]R'9.4;)'TXKO<#GBN$OD"7\^T_\
MM#4T&3$USXE?_GV'YT'Q*W_/L/SK!"L3@#=3Q!,5SY,A7U$9JO9Q'9&V?$K\
M_P"C#\ZF@\2H\BK-;,H[$'I7/FWG'_+"3_OD_P"%2V]A=SR*B0R`'N4QBIY(
MBY4=OC+;L[E(SD5R>OVZP:@VW`$@SS75HGEQ1KD':FVN:\3-_IT8'WE3FLZ7
MQ!'>QT=N@2VC1>-J*?TK#U;5KFSO6AAV(JC.-N<U>TB\2\LT3<OF(-I!/)JW
M<V-M=E3-"CL!C=TQ19*7O(E>[+4Y8:]J(_C3_OFMW1+N6]LVEG?>X8CIBI/[
M$T__`)]Q^9JS;6D5G$T4*!%)S3G*+5D.31E^)O\`CQC_`.NE4?#H_P")@P[>
M5_6K_B;_`(\(_P#KI5#P[_R$3_UR_K37P#C\)N:F!_9ESQ_RSKBFX4_2NVU/
M_D%W/_7.N(;[IX[4Z!43?\.#_2+L>P_F:TM=`_LJ;IU%9OAS_CYO/H/YFM/7
M?^05-]12G\9+^(X_N"<8[UVFDQB+2[0+_P`\P?KG-<41QVZ5VVG#_B6VO_7%
M?Y&JK[#D4=;U6:QE6&WP)"-Q;'05@W6I75W&%E8-Y?(XQ5OQ!_R%3_NUEH`S
M@'H2,U5.*Y;@E[IV6EVB6>GHJJ2S#>Q[U5UC5GL)5MX8U:7&XL>PK8"A<*O`
M`'\JKSV%G/-YDEO&[8P20:P37-J1U.<.OZ@>\?\`WQ2'7K]@03'@CGY.U=#_
M`&1I_P#SYP_E3)=)L!#(5M(@0I(('3BK4X]BKHXWD*-PRPSG\:0C@T'/S8&%
M#$4'H:WZ&A]H>&O^15T?_KRA_P#0!11X:_Y%71_^O*'_`-`%%?(U/C8SXOH/
M2B@U]<([?3_^09:_]<DJT1GMG\*JZ=_R#;;_`*Y)63XAGF@GA".Z;E_A:N5*
M\C*UY'0;?]G]*7&.@QCO7"?;;K_GYD_.GP:E?0,K)</N]":T]DQ\IV=V9UMF
M:WC1IA]T$UQ$\DLMS(T^?,W?-N'2NV@<S6R3E"ID7=CTKGO$ENL=U%,J\2KA
MO^`U-)V=@CO8T]"_Y!,?U:J?BC_4P?[U7-!!.DQ\=VJGXH'[J#C^*G'^('VA
M/#4ZJ9H&'SL-ZBM75+,WMC+$@P^,K7&VTSVUPDT;8=6R0?2NOL=3M[Y%VL$E
M[HQY_P"`^M$XM.Z"4=;G&R1O&[(X967^\*U-"T^2XO5G*8BC.=S?Q5U+P12'
M+Q(Y]2M.<QPKEF6-%_O'%#JMJP<XCN(XG<G`5>I[UQ$<<E_?F-/O2R$Y'\-:
M6L:PLZFWMV_=Y^8_WJC\.HK:D7/\*$TXIQ5V-*RN;]IIMK91J$B4M_$[=35W
M&!P,#VI'.U6;&2`37$7.H7=S.9&E<`G@!L;:B*<NI*5SN,'WHP1R,@^M<%]I
MN/\`GO)_WU09YF_Y:R?]]57L/,?*=K<7EO:0M)+(@/\`<_B/X5QE]=M>WKS,
M"N_A#Z"H22W4DGU-'?\`&M(041K0%8HV5.T]>#BK(U2]5<"ZE7\0:W]`A633
M,O"K'>><9K4^SP_\\(_P2IE42=K!*1QW]KW[?=NI#[8%=/I'VIK)9+HN[L>`
M_&*NK;Q)]R%!^%1SW$-NF9I$1?\`:;FLY24E9(3=S(\2G%K`.[L:I^'?^0DW
M_7+^M5=3U'[?=AE&(8^%5N"?>K7AP'^T'XY\JM+6AJ%M+&[J?_(+N/\`<KBM
MK>A'_`:]!*Y&"N?PI/*7^X/RK.-3EZ`G8P/#=NZB>:0%4;H",$U=UYE72)">
MI8"K\CQP+F1@BCNQZ5S6N:E'<M%!"<Q(<D^I]:(WE*X;R,4]Z[C31_Q+;3_K
MDO\`(U0T&VBDTI6>*-\L>66M=454"*I11T`%.L[JP2EI8Y7Q%QJQ_P!VLK&3
MBN^:V@D;+P(Y]2M8GB*"*&TB9(U7+=`O6KISO[H1E?0U[>=9[6.=.3(H;'Z5
MC:Y-?VUT9(II5A*@97H#Z57T?5A:*;:X&82<JP_A]JZ2.2"Y0&-TD4CH#FH:
M<'<-G<XW^U;[_G[?_OK_`.M0=5O3]ZZ<@]1G_P"M79_9X_\`GFO_`'S4<\$8
MMY2(E^XW\/M351=@N<(2Q!W'.3FE/0TI'S-Q_$:0]#6[-#[0\-?\BKH__7E#
M_P"@"BCPU_R*NC_]>4/_`*`**^1J?&QGQ?0:*#TKZX1V^G?\@NS_`.N253U?
M2IM0EB>)U&U?XJ2RUBPAL8(Y+A494VMPU6?[9T[_`)^E_P"^&KF?-%W2,?>Y
MC%_X1J[_`+\7Y4Z/PU.73S)T"_[(K8_MG3O^?I?^^&IC:WIH_P"7G=_P!J?/
M/L/FD:"1JD:Q*N%5>]<YXGF1IH84^\B[FJW<>([=$98$:5O]JN9FFEFG:61M
MTK-NW55*#O>0XQUN:EEH]S>VRS1W*QH[;>AJ'4M.N+)(C+,LFYMORC-:FD:C
M96VG)'-*%DW;L;:K:_>6MW'`+>0,R-NX6G>7-L/4Q,=Z.AR.".GM1VHK4LG6
M]NE7:MQ*JCT;-,>>:9MTK.S>C-4>*"*!6#M6GH,ZQ:HF[Y0XVBLRE!(((Z@Y
M%*2NK$GH)`(Y%<[=>&F>4O;3!06+;66EL_$:;5CO(W/8.HK0&MZ<RY-SC_>2
MN:TX["Y7$Q_^$:N_[\7Y4?\`"-7?_/2+\JVCK.G?\_2_]\-1_;.G?\_2_P#?
M#5?//L+FD8O_``C-X>/.B_*LJ2-H)7C8@LC%3MKK_P"V=.S_`,?2_P#?+5R5
MVR/=S,C!HRY8$>]:0<GN7&_VB(2R(,`D?0TOG3?\]6_.FXHQ5E"^;+_ST;\Z
M"2?O$GZTE%`!CO2@E3E20?8XI**`'>=+_P`]6_.CSI?^>K?G3:,4"L*69ARQ
M/U-)CVHHIC'"61<J"P'3@UV^G\Z;:DG),*_R-<,1D8]:ZNSUBP2R@BEN%5E1
M0?D;T-95DWL1(RM?E=-4(#$#;V-91DD;AF)^IK1UNY@N]1\V!@R%<`A?2LRJ
MI_"./PB]O:E!*\J2/H<4E%44.\Z7_GJWYT&64@@R$CZTW%&*!6#M0>AHH/0T
M,9]H>&O^15T?_KRA_P#0!11X:_Y%71_^O*'_`-`%%?(U/C8SXOH-%!Z5]<(]
ME\-_!&RUWPWI^K2:U<PO>0+*8UB7Y=U:G_#/5C_T,%Y_WY6NX\((TOPFTM(U
M+.^E*JJO?Y*^;D\#^,-H!\.ZSG'/^CO7BTJU6I.:=7EL,[_7_@1J&G6,]YI6
MIK?N@W?9Y(=KGW5MWWJI^!?A):>+O"D>M/J\]LTK,OEQQ+_#7KWPVL-4TWP#
MI]KK"R+>)YA,<C?-&NYMJG\*I_"9H9?!#O!M^S-?W1BV_P!WS3M_2L98VLE)
M<U[.U["L?+*G<BMZC-+7M.G:+\&XKR#1FGN+V\+B$32/.%:3[O\`#M7K6/\`
M%?X<Z=X.MK34]):1;6>7R'@E?<4<*S*RM][^%J]2&-@Y*$DTWM<#R[WHP*]J
MT#P%X$T[PA%K/B>^2YG>W%Q)&MWM\M6&Y555;=NQ5CP[H7PE\:74NG:587L5
MVB%PKSS`X'=<NRFIEF%--V3:6[Z`>&]J*]&N/`%IHOQ<T[PU=/)=:?=%7`9B
MC/&VX$,R^ZUW7B7P-\,/"K6UUJZ7-O;R;D6W2>9S(WKP=WR_UIRQ]--))N^U
M@/G^BO;/''PT\-6_@[_A(O#J26ZJJ2A3+(ZS1MZAN5ZUMZI\+?`5CX<BU.]$
M^GQ(D4D]P+B1^#C(VMN^]TZ9YJ?[1I63L]78#YXQ17OF@>$OA1XO:XL]%AN&
MN84W,3+<*R@\;AO.WTK,O/!WPR\%71L_%&HW=Y>/ET3,H\M.W^KI_P!H0OR\
MKOVL!XM17N/B[X7^%CX)G\0^&5FMQ%!]H3]X[I,@Y(*O\U8_P]\`^%=4\.G6
M_$M^A+%BMM]K\H*J]SC#9H6/I.#G9^G4#R:C%>U:79_!C7]7BTFQL[L74[;(
MBTUP`S>QWUSOQ"^&J>&=>TVWTF21[74I!'$LIW/%)GH#W'>JAC82ERR35^X'
MF]'%>^7GPV^'W@G1X;GQ3+<7$DC>7YADE`=\9(58N?SI^D_#_P"&GC;3KEO#
MRW<,D)V/(DLV8W(R#B0D'\*AYA3M?E=N_09X!17HWA'X9-K7C'5='U*X=+32
MI-DYC7!D)/RA3[]3[5U&IZ?\%M!U*?2]06<W=NVV4"6Y;:1_NG;WJIXZFFHQ
M3?H(\1HKV7QM\+]`@\(OXG\+32BWCC6;8\A=)(R>JD_,#S5O0/AOX8O_`(6)
MKT]C(=1:Q><2K<R`!PIQ\H;':CZ_2Y5+SL,\0H^AP>QK>\$:7:ZWXTTC3K]#
M);7,VR1`^"1M8]N>HKT7Q[X*\%^$O$'A[=:RVVE7,CB^/GR.2H''5L]?3FM*
MN+A"?L[.XCS-_"NOQZ<=3DT:]2R$8D\_;\H0]_Q-8QP%)(X`Z5]=W_\`PCG_
M``KUA<F3_A'3:KD@R;O*XQ_M>GO7B/BQ/A2/#5W_`,(U)-_:J@>2&-QUSS]_
MY>E<^'Q[G=.+^7Z]AV':I\,-*T[P&^OQZ_YERELD_P!G^3EB0,9'/1J\Q[5[
MAKOPZ\,V/PHEUV#3Y5U!;&.<2&YD;#,5W?*6V\@TSPW\+/#-EX07Q%XNFE=6
MB$\B(YC2)3]W[G))!%32QD8Q;DV];;`>)48KWG0O#OP@\5WKZ=I%O<&[VEL>
M=<*<#ODG!K@/%/@`:!\0;3PZEZ/LMZ8Y(IYR%V1EBIWD\$C!Q713QM.4G%II
M^8K'"XP*,9X]>*]UU;PM\)_!UC;?VLTU_+(WEATNG:1B!GD1LH`Z5/IGPZ^'
M?CG0I[KPTMY9LCF(2&21MDFT'!#E@1@KTK/^T*>[B[=[`<!\-O`-OX\?4Q/?
M3V@M?*?:B9SO+<Y_X!7->*]#C\.>)[[2(YGF2UD\L2.N,\9KUSX"VLEEJ?BN
MTF`$L#P1R?+M^8-+S^(K//@FV\:_&OQ%;7\LB6=L1+(L9PSY(`&?0UE'%N->
M;<O=2"QXWVI:]N\1Z?\`"#POJ\FE:EIM])>1@-($EG.`WS`_?`[]A6;XN\&_
M#^3PI-J_AC5[>"Z2$7"6SWPD,B]UV,VX-V^M;0Q\9-7BTGUMH!Y%0>AHH/0U
MW,#[0\-?\BKH_P#UY0_^@"BCPU_R*NC_`/7E#_Z`**^1J?&QGQ?0>E%%?7"/
MK3P5*UM\+=&N``S1Z;'(N?\`<KR-?V@_$14'^R=)Y'I)_P#%5S5G\4O%>FZ/
M%HD5W;I;0P^0D9M58^7C^]]*XP+@#':O+H9?'GFZJO?8+GH6N_&3Q5K5C)8[
MK*QAF#K(UK&VXK_O,S?^.UZU\%ACX96W_7>;^=?,==?H?Q(\4>%]'73M-N+>
M.T1V**]NK'/\57B<%S4N2DDM;@<_X9_Y&#2/^OJ+_P!"6O?/V@!GP;I@/0ZF
M@/\`W[DKYYM)YK&[MY[=]LL,BLF?[W\-=)XE\?>(?%6G16>M7,4MO#,)E`@5
M#NVL/X?]DM55\-.=2$H[+<+GT!/:P>!/`JW?AGP\FH7,<,8$5O'^\G!VY=BJ
MEF_O5F^"?%.L^(_$)_M;P0VF&.)F2^>W>/:<\IN9>]>.:-\4_%N@:=%:VNHI
M+:PC:B74"OL']T,/F_.K;?&;QO+=QN-1MT(Z1+:KM;_>KC>`JZJR=^MPN=[X
MN_Y.'\-?]>\7_H<E4/VAA^]\/\=IOYI7G%[XX\0:AXEM_$5U-&VH62+&DJPJ
M$7EBN5_BY-0^*?&6M>*S:G7)HI#;[O)(@5-H;&?N_A6U'!U(5(2=K+<+E,Z]
MK$ULEA-J]^]D<1^0;AC'M!^[MW;:^A/BJ/\`BS4W_7.V_FM?-`X8,.HYKK-7
M^(WB7Q!H;Z+>W-O+:,$#*MLJ-A<;>?RKHQ&%E.I"4+63NPN=;^S]_P`C9J?_
M`%X_^U!61\;./B3<_P#7K%_6N8\,^*=5\*W<]YHLRI--%Y;LT*OP&']ZJ_B#
M7M1\1:O)J&J2JUVZJC,L2ID?\!H5"?UEU>EK!<^B(./@*3V_LD_R-0?#O1=.
MT7X:6FL:=I:7NI2VS3L57][,V3A`W;IC%>,#XE>)(?#O]@?:K=;'[.8#']F4
MML.<_-4?AKX@>)?"]J+/2M0;[.YWK#+$L@S[%N5KC>!JN,DGUOZA<]?T+QKX
MB\0^)+"TU7X?2P6QE'^DR6T@^S$9^?<Z;>/;UJ3XL74=KXB\&SRL%CCO\L3V
M[5YE/\9O&TQ1AJ$$*J<G9:IS^=8/BCQOKWBO[-'K5S'(+9BT16$(<X_V:J&!
MJ^T4FDEZA<]L^-V@:MKNA::VE6$]XT%P[21P1[W`*8R!7#>!?A+J^L07<VIS
M:CH>UAY2M#M9^.NUNE86E?%GQCHT"6L>I+/%&FV-+J!7P/3<,-^;&I;_`.,/
MC6[MGA;4(+9&!#-!;+N/XFJAA\53@Z4&K=PN>C?".V@TSQ+XLT9+MKF2WG7$
M[_>D4<;C^.:L^)/%WC72M>N[.R\#+?6BR'R+E()'$B>Y48!KP+2M8U/1]234
M-/O)H+P,1YJD$DGDY!X-=JOQM\:P1[9+JS<CC?):KN/X+Q2JX&I[1S5I:==/
MR"YZ?XHN?%T_PZU&XU.UT6RMGLLRP_O/,CSC(Y^7TJ[X(A>\^"MM!;+OEDT^
M1$4=2VT@#\Z\(\0_$'Q/XJMA9ZGJ`:W(W>1#$J(<=V[FF>&O'7B7PS;-!I%Z
M5LV.3!+&LD8/J`>1FI^H5?965D[W"YTOPU\#^);;QYI=W=Z+>6MM9R;YI;B+
MRUQM88'][D]:Z;]H;[NA]^)?Z5Q-W\7_`!M=O&YU*.`1'>$@MT`;ZYZBL;Q1
MXRUOQ;):IK<\4GV<MY6(53KU^[6T</7E652I;0+GO][;3ZK\$%@LH9+B>;2X
M_+CC&6?[IX'K7F$/PA*>`)_$&K7UU87<4$DK6<EO@+C[H.[G)XKGM$^)OBKP
MOIZ6%E>HUM&,I'<Q"3:,_P`)Z@>U,\0_$7Q5XFLFM-1OD%FY!:&VA6-9/<G[
MQQZ=*SIX7$TY-0:LW<+GMOBG/_"A)L#G^S(?YI4OB.TG\0_!)X-(C:YFGL(6
MACC/,@#*W'J<`UX9=?$GQ)?>'6T&XN;9K!H%A91;*&"+@CFF>&_B!XI\,6RV
M6E7["V`+BVEC21%'J"W(^E9K+ZUN96NG<+FKX/\`AEX@UC7S;W]IJFC0!&)N
MVMFC.<],]ZV#X$T_3_C!HGA^^U*758)8S/,MP,=%=EC(W'(X!Q_M5ES_`!K\
M;31E1=6D`QRR6PS7&3ZOJ=SK0U2:\N'U/S1()R^6#CG*GL/:NE4<5.3YVDO(
M+GTGXT\0ZGX.CM+3P_X/-_;R+AV@A8QQ@=`51:T?`.HWFK:3<7U_X:.A74ER
M0\1B,?G?*N),%0?;G^[7AMM\:/&T,:Q?;+:9@,!I+9=WU)[TQ?C)XXB>4G48
MW!8DAK2/"C':N1Y=6Y>6ROWN%ST3X/?\CCX\X_Y?$_\`1DU9NFPZVWQQ\3S:
M%<:>LT2@S0WH<)+'A.05[AL5YOH'C_7_``Y>:IJ&GR6XEU&42W+RP*06RQ&`
M.G+-5-O%VM'Q9-XCM[PP:I*V]I+=0JD'C!4\'Z&ME@JKE)Z:JP7/=]>\=^)=
M$U5]/G\!3:HJ!66YM#(T;D]0/W+=/K_#5C6M$TKQ9\.+K4]4\.1Z5>_8I9D6
M2,+-:LJL1E@%..,X/7TKR@?&[QK&@5[FQ..-TEL,GW^6LC7OB/XL\36$EK?Z
MB19O_K(8(UB5O0$CYB/8U$<!6YDTDK=;L+G(GC=MRWS%05Z$#O0>AHQQ0>E>
GRP/M#PU_R*NC_P#7E#_Z`**/#7_(JZ/_`->4/_H`HKY&I\;&?__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
